Recap: Acasti Pharma Q4 Earnings


Acasti Pharma ACST reported its Q4 earnings results on Tuesday, June 21, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.


Acasti Pharma beat estimated earnings by 60.0%, reporting an EPS of $-0.04 versus an estimate of $-0.1.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.23 which was followed by a 4.92% increase in the share price the next day.


To track all earnings releases for Acasti Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps